Results 181 to 190 of about 1,703,563 (293)

Right and left-sided carcinoid heart disease

Cardiology Journal, 2018
Ilona M, Michałowska, Agnieszka, Kolasinska-Ćwikla, Jarosław, Ćwikla, Dariusz, Zakrzewski, Mariola, Pęczkowska   +4 more
openaire   +3 more sources

Characteristics and Outcomes of Male Participants in a Multicenter Longitudinal Australian Study Cohort

Arthritis Care &Research, EarlyView.
Objective The aim of this study was to determine the differences in demographic, serologic, and clinical characteristics between male and female patients with systemic sclerosis (SSc) in an Australian cohort. Methods This was a retrospective observational study using data from the Australian Scleroderma Cohort Study.
Emily Lin, Dylan Hansen, Laura Ross, Gene‐Siew Ngian, Susanna Proudman, Gabor Major, Maryam Tabesh, Mandana Nikpour, Jennifer Walker, Lauren Host, Nava Ferdowsi, Alannah Quinlivan, Wendy Stevens, Joanne Sahhar, Diane Apostolopoulos   +14 more
wiley   +1 more source

Novelties in Pulmonary Hypertension Secondary to Left Heart Disease

Barcelona Respiratory Network Reviews, 2022
Juan J. Rodríguez-Arias, Eduard Solé-Gonzalez, Ana García-Álvarez   +2 more
doaj   +1 more source

Obesity subtypes and longitudinal trajectories of function over 7‐years of follow‐up: data from the Multicenter Osteoarthritis Study

Arthritis Care &Research, Accepted Article.
Background Obesity, defined by BMI ≥30kg/m2, is a risk factor for functional limitations in people with knee osteoarthritis (OA). However, function varies among such individuals. Our objective was to evaluate the implications of obesity subtypes on longitudinal patterns of physical functioning in people with or at risk for knee OA.
Kristine Godziuk, Sarah Tilley, Michael LaValley, Michael C. Nevitt, Cora E. Lewis, James C. Torner, Tuhina Neogi   +6 more
wiley   +1 more source

Evaluation of early bilateral ovariectomy in mice as a model of left heart disease.

Am J Physiol Heart Circ Physiol, 2022
Joll JE, Bersi MR, Nyman JS, Merryman WD.   +3 more
europepmc   +1 more source

The impact of cardiovascular comorbidities associated with risk for left heart disease on idiopathic pulmonary arterial hypertension: Data from the Hellenic Pulmonary Hypertension Registry (HOPE). [PDF]

Pulm Circ, 2022
Arvanitaki A, Vrana E, Boutsikou M, Anthi A, Apostolopoulou S, Avgeropoulou A, Demerouti E, Patrianakos A, Karyofyllis P, Mitrouska I, Mouratoglou SA, Naka KK, Orfanos SE, Panagiotidou E, Pitsiou G, Rammos S, Stanopoulos I, Thomaidi A, Frogoudaki A, Boutou A, Anastasiadis G, Brili S, Tsangaris I, Tsiapras D, Voudris V, Manginas A, Giannakoulas G.   +26 more
europepmc   +1 more source

Prognostic value of non-invasive right ventricle-pulmonary artery coupling in patients with pulmonary hypertension associated with left heart disease. [PDF]

J Cardiothorac Surg
Dou LZ, Li SS, Wang S, Jiang H, Zheng YL, Duan MM, Zhang YG, Han B, Li JM, Ruan HY.   +9 more
europepmc   +1 more source

Outcomes of pulmonary vasodilator use in Veterans with pulmonary hypertension associated with left heart disease and lung disease. [PDF]

Pulm Circ, 2021
Gillmeyer KR, Miller DR, Glickman ME, Qian SX, Klings ES, Maron BA, Hanlon JT, Rinne ST, Wiener RS.   +8 more
europepmc   +1 more source

Artificial Intelligence in Systemic Sclerosis: Clinical applications, challenges, and future directions

Arthritis Care &Research, Accepted Article.
Systemic sclerosis (SSc) is a rare autoimmune disease defined by immune dysregulation, vasculopathy, and progressive fibrosis of the skin and internal organs. Despite advances in care, major complications such as interstitial lung disease (ILD) and myocardial involvement remain the leading causes of morbidity and mortality.
Cristiana Sieiro Santos, José Miguel Sequí‐Sabater, Diego Benavent   +2 more
wiley   +1 more source

Dysregulated fatty acid metabolism in pericardiac adipose tissue of pulmonary hypertension due to left heart disease mice. [PDF]

FASEB J
Qiu H, Chen J, Mei Z, Chen W, Jun L, Chen Y, Tan Y, Wang T, Chen Y, Li J.   +9 more
europepmc   +1 more source